Antti Saari

Antti Saari

Auto-generated profile, based on publicly available information

Antti Saari

Department of Pediatrics Kuopio University Hospital Kuopio Finland

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Pediatrics
Verified
Journal Article
Closed access
ASAntti Saari
Antti Saari
LVLauri J. Virta
Lauri J. Virta
USUlla Sankilampi
Ulla Sankilampi
LDLeo Dunkel
Leo Dunkel
HSHarri Saxen
Harri Saxen
OBJECTIVE: Antibiotics have direct effects on the human intestinal microbiota, particularly in infancy. Antibacterial agents promote growth in farm animals by unknown mechanisms, but little is known about their effects on human weight gain. Our aim was to evaluate the impact of antibiotic exposure during infancy on weight and height in healthy Finnish children. METHODS: The population-based cohort comprised 6114 healthy boys and 5948 healthy girls having primary care weight and height measurements and drug purchase data from birth to 24 months. BMI and height, expressed as z-scores at the median age of 24 months (interquartile range 24 to 26 months), were compared between children exposed and unexposed to antibiotics using analysis of covariance with perinatal factors as covariates. RESULTS: Exposed children were on average heavier than unexposed children (adjusted BMI-for-age z-score difference in boys 0.13 SD [95% confidence interval 0.07 to 0.19, P < .001] and in girls 0.07 SD [0.01 to 0.13, P < .05]). The effect was most pronounced after exposure to macrolides before 6 months of age (boys 0.28 [0.11 to 0.46]; girls 0.23 [0.04 to 0.42]) or >1 exposure (boys 0.20 [0.10 to 0.30]; girls 0.13 [0.03 to 0.22]). CONCLUSIONS: Antibiotic exposure before 6 months of age, or repeatedly during infancy, was associated with increased body mass in healthy children. Such effects may play a role in the worldwide childhood obesity epidemic and highlight the importance of judicious use of antibiotics during infancy, favoring narrow-spectrum antibiotics.

1 March 2015 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
ASAntti Saari
Antti Saari
SHSamuli Harju
Samuli Harju
OMOuti Mäkitie
Outi Mäkitie
MSMarja-Terttu Saha
Marja-Terttu Saha
LDLeo Dunkel
Leo Dunkel
USUlla Sankilampi
Ulla Sankilampi
Growth-monitoring programs have been a fundamental part of preventive child health care for more than a century.1 Ideally, screens for abnormal growth aim to detect treatable illnesses before any other symptoms of the disease appear. Early diagnosis helps to minimize the impact of the underlying condition and optimize final adult height.2,3 During growth screening, height and weight values should be compared with the pre-established cutoff values that define normal growth.4 Despite the long tradition of growth monitoring, evidence-based cutoffs for clinical pediatric practice are insufficiently explored and studies that aim to define such norms are scarce.2-5

1 November 2012 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
ASAntti Saari
Antti Saari
USUlla Sankilampi
Ulla Sankilampi
MHMarja-Leena Hannila
Marja-Leena Hannila
MSMarja-Terttu Saha
Marja-Terttu Saha
OMOuti Mäkitie
Outi Mäkitie
LDLeo Dunkel
Leo Dunkel
Screening criteria for abnormal growth in children are traditionally based on height-for-age, height distance from target height (TH), and change in growth rate. However, there is no consensus on the optimal screening limits. Our objective was to first develop new population-based and age-specific cutoffs for these three screening parameters and, second, to validate their performance in screening by using Turner syndrome (TS) as a model. Reference values for the height distance from TH and growth rate were defined in a total of 14,189 healthy girls aged 0-18 yr with 147,469 height measurements. The best formula for TH calculation was TH sd score = 0.79 × mid-parental height sd score - 0.15. We also calculated age-specific limits for the distance from TH and limits for growth rate that were freely scalable between age range 0-12 yr. Longitudinal growth data of a cohort including 124 TS girls were evaluated with receiver operating characteristic analysis against the reference population. The screening accuracy for TS was excellent when we combined all three screening parameters. Sensitivity was 97% and specificity 96% for all TS girls and 100% and 95% for 45,XO TS girls, respectively. The detection rate was 68% for all and 76% for 45,XO TS girls with 99% specificity by the age of 2 yr. These new population-based screening rules for TS are sensitive and specific, but their use is complex, and therefore their efficient use requires computerization.

20 May 2013 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
TMTaina Mustila
Taina Mustila
JRJani Raitanen
Jani Raitanen
PKPäivi Keskinen
Päivi Keskinen
ASAntti Saari
Antti Saari
RLRiitta Luoto
Riitta Luoto
According to current evidence, the prevention of obesity should start early in life. Even the prenatal environment may expose a child to unhealthy weight gain; maternal gestational diabetes is known to be among the prenatal risk factors conducive to obesity. Here we report the effects of antenatal dietary and physical activity counselling on pregnancy and infant weight gain outcomes. The study was a non-randomised controlled pragmatic trial aiming to prevent childhood obesity, the setting being municipal maternity health care clinics. The participants (n = 185) were mothers at risk of developing gestational diabetes mellitus and their offspring. The children of the intervention group mothers were born between 2009 and 2010, and children of the control group in 2008. The intervention started between 10–17 gestational weeks and consisted of individual counselling on diet and physical activity by a public health nurse, and two group counselling sessions by a dietician and a physiotherapist. The expectant mothers also received a written information leaflet to motivate them to breastfeed their offspring for at least 6 months. We report the proportion of mothers with pathological glucose tolerance at 26–28 weeks’ gestation, the mother’s gestational weight gain (GWG) and newborn anthropometry. Infant weight gain from 0 to 12 months of age was assessed as weight-for-length standard deviation scores (SDS) and mixed effect linear regression models. Intervention group mothers had fewer pathological oral glucose tolerance test results (14.6% vs. 29.2%; 95% CI 8.9 to 23.0% vs. 20.8 to 39.4%; p-value 0.016) suggesting that the intervention improved gestational glucose tolerance. Mother’s GWG, newborn anthropometry or infant weight gain did not differ significantly between the groups. Since the intervention reduced the prevalence of gestational diabetes mellitus, it may have the potential to diminish obesity risk in offspring. However, results from earlier studies suggest that the possible effect on the offspring’s weight gain may manifest only later in childhood. Clinical Trials gov: NCT00970710

1 May 2023 in EBioMedicine
Verified
Journal Article
Open access
MAManu Airaksinen
Manu Airaksinen
ETElisa Taylor
Elisa Taylor
AGAnastasia Gallen
Anastasia Gallen
EIElina Ilén
Elina Ilén
ASAntti Saari
Antti Saari
Sampsa VanhataloSampsa Vanhatalo
Sampsa Vanhatalo
Early neurodevelopmental care and research are in urgent need of practical methods for quantitative assessment of early motor development. Here, performance of a wearable system in early motor assessment was validated and compared to developmental tracking of physical growth charts. Altogether 1358 h of spontaneous movement during 226 recording sessions in 116 infants (age 4–19 months) were analysed using a multisensor wearable system. A deep learning-based automatic pipeline quantified categories of infants' postures and movements at a time scale of seconds. Results from an archived cohort (dataset 1, N = 55 infants) recorded under partial supervision were compared to a validation cohort (dataset 2, N = 61) recorded at infants’ homes by the parents. Aggregated recording-level measures including developmental age prediction (DAP) were used for comparison between cohorts. The motor growth was also compared with respective DAP estimates based on physical growth data (length, weight, and head circumference) obtained from a large cohort (N = 17,838 infants; age 4–18 months). Age-specific distributions of posture and movement categories were highly similar between infant cohorts. The DAP scores correlated tightly with age, explaining 97–99% (94–99% CI 95) of the variance at the group average level, and 80–82% (72–88%) of the variance in the individual recordings. Both the average motor and the physical growth measures showed a very strong fit to their respective developmental models (R2 = 0.99). However, single measurements showed more modality-dependent variation that was lowest for motor ( σ = 1.4 [1.3–1.5 CI 95] months), length ( σ = 1.5 months), and combined physical ( σ = 1.5 months) measurements, and it was clearly higher for the weight ( σ = 1.9 months) and head circumference ( σ = 1.9 months) measurements. Longitudinal tracking showed clear individual trajectories, and its accuracy was comparable between motor and physical measures with longer measurement intervals. A quantified, transparent and explainable assessment of infants' motor performance is possible with a fully automated analysis pipeline, and the results replicate across independent cohorts from out-of-hospital recordings. A holistic assessment of motor development provides an accuracy that is comparable with the conventional physical growth measures. A quantitative measure of infants’ motor development may directly support individual diagnostics and care, as well as facilitate clinical research as an outcome measure in early intervention trials. This work was supported by the Finnish Academy (314602, 335788, 335872, 332017, 343498), Finnish Pediatric Foundation (Lastentautiensäätiö), Aivosäätiö, 10.13039/501100006306 Sigrid Jusélius Foundation , and HUS Children’s Hospital/HUS diagnostic center research funds.

8 May 2012 in Journal of Negative Results in BioMedicine
Verified
Journal Article
Open access
PDF file
TMTaina Mustila
Taina Mustila
JRJani Raitanen
Jani Raitanen
PKPäivi Keskinen
Päivi Keskinen
ASAntti Saari
Antti Saari
RLRiitta Luoto
Riitta Luoto
Fetal conditions are known to be partly responsible for the child’s risk for obesity. Our pilot study aimed to determine the effect of gestational lifestyle counseling on the offspring weight gain until 4 years of age and to estimate power for future studies.